Clolar and atrial fibrillation Patient Reports February 13, 2012

Clolar Side Effects Report #5748658-9
Clolar side effect was reported by a Physician from UNITED STATES on May 16, 2008. Male patient, 72 years of age, was diagnosed with myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , bundle branch block right, cardio-respiratory arrest, liver function test abnormal, pulse absent, tachycardia. Clolar dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.

Clolar Side Effects Report #5767144-3
Clolar side effect was reported by a Physician from UNITED STATES on June 03, 2008. Male patient, 72 years of age, was diagnosed with myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , bundle branch block right, cardio-respiratory arrest, liver function test abnormal, pulse absent, sepsis , tachycardia. Clolar dosage: unknown. During the same period patient was treated with CYTARABINE. Patient died on 05/29/2008.

Clolar Side Effects Report #5090936-3
Clolar side effect was reported by a Physician from UNITED STATES on Aug 14, 2006. Male patient, 75 years of age, weighting 157.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: acinetobacter infection, activities of daily living impaired, asthenia, atelectasis, atrial fibrillation , bacteria blood identified, bacteria sputum identified, bacteria urine identified, bedridden. Clolar dosage: 40 MG QD IV. During the same period patient was treated with CYTARABINE. Patient died on 11/05/2005.

Clolar Side Effects Report #4845231-1
Clolar side effect was reported by a Physician from UNITED STATES on Nov 18, 2005. Male patient, 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , bacterial infection , blood culture positive, cardio-respiratory arrest, confusional state, disorientation, electromechanical dissociation, febrile neutropenia. Clolar dosage: 40 MG QD IV. During the same period patient was treated with CYTARABINE. Patient died on 11/05/2005.


Clolar Side Effects Report #4855955-8
Clolar side effect was reported by a Physician from UNITED STATES on Dec 06, 2005. Male patient, 75 years of age, weighting 157.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: acinetobacter infection, activities of daily living impaired, ammonia increased, atelectasis, atrial fibrillation , bowel sounds abnormal, bradycardia, cardio-respiratory arrest, cellulitis . Clolar dosage: 40 MG QD IV. During the same period patient was treated with CYTARABINE. Patient died on 11/05/2005.

Clolar Side Effects Report #4918837-9
Clolar side effect was reported by a Physician from UNITED STATES on Feb 09, 2006. Male patient, 75 years of age, weighting 157.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: acinetobacter infection, activities of daily living impaired, asthenia, atrial fibrillation , bacterial infection , bedridden, blood creatinine increased, bowel sounds abnormal, bradycardia. Clolar dosage: 40 MG QD IV. During the same period patient was treated with CYTABABINE. Patient died on 11/05/2005.

Clolar Side Effects Report #4740483-0
Clolar side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 28, 2005. Male patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: arrhythmia , atrial fibrillation , cardiac arrest , creatinine renal clearance increased, dehydration, diarrhoea, dyspnoea, effusion. Clolar dosage: 20 MG/M2 QD X 5 IV. During the same period patient was treated with CLOFARABINE, VORICONAZOLE, AMIODARONE, METRONIDAZOLE, ACYCLOVIR, POTASSIUM CHLORIDE, METOCLOPRAMIDE, LINEZOLID. Patient was hospitalized. Patient died on 06/11/2005.

Clolar Side Effects Report #4998214-5
Clolar side effect was reported by a Health Professional from UNITED STATES on Apr 28, 2006. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , base excess increased, blood bicarbonate increased, breath sounds abnormal, carbon dioxide increased, cardiomegaly, cardiomyopathy , condition aggravated, crepitations. Clolar dosage: 22.5 MG/M2 IV. During the same period patient was treated with CYTOSINE ARABINOSIDE. Patient died on 04/27/2006.

Clolar Side Effects Report #5018834-1
Clolar side effect was reported by a Physician from UNITED STATES on May 17, 2006. Female patient, 71 years of age, weighting 213.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: ascites, atrial fibrillation , blood bicarbonate increased, cardiac disorder, cardiomegaly, dilatation ventricular, electrocardiogram abnormal, electrocardiogram t wave abnormal, embolism. Clolar dosage: 22.5 MG/M2 IV. During the same period patient was treated with CYTOSINE ARABINOSIDE. Patient died on 04/27/2006.


Clolar Side Effects Report #4970028-1
Clolar side effect was reported by a Physician from UNITED STATES on Mar 22, 2006. Male patient, 67 years of age, weighting 161.6 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , bacteraemia, bacterial infection , blood electrolytes decreased, bowel sounds abnormal, catheter related infection, catheter site erythema, chills, febrile neutropenia. Clolar dosage: 19 MG DAILY IV. During the same period patient was treated with CYTOXAN. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #4987374-8
Clolar side effect was reported by a Physician from UNITED STATES on Apr 10, 2006. Male patient, 67 years of age, weighting 161.6 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, atrial fibrillation , bacteraemia, blood electrolytes decreased, bowel sounds abnormal, catheter site erythema, chills, febrile neutropenia, tachycardia. Clolar dosage: 19 MG DAILY IV. During the same period patient was treated with CYTOXAN. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #4823528-9
Clolar side effect was reported by a Physician from UNITED STATES on Oct 25, 2005. Male patient, 60 years of age, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , bacterial infection , blood culture positive, cardio-respiratory arrest, confusional state, disorientation, electromechanical dissociation, febrile neutropenia, hypotension. Clolar dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.

Clolar Side Effects Report #4970056-6
Clolar side effect was reported by a Physician from UNITED STATES on Mar 23, 2006. Male patient, 49 years of age, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, atelectasis, atrial fibrillation , cerebral artery embolism, cerebrovascular accident, disseminated intravascular coagulation. Clolar dosage: 76 MG IV. During the same period patient was treated with HIDAC. Patient died on 03/19/2006.

Clolar Side Effects Report #5813859-8
Clolar side effect was reported by a Health Professional from UNITED STATES on July 08, 2008. Female patient was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood alkaline phosphatase increased, cerebral haemorrhage, chest discomfort, clostridium difficile toxin test positive, colitis, ejection fraction decreased, endophthalmitis, rash . Clolar dosage: 30 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient died.


Clolar Side Effects Report #4591593-2
Clolar side effect was reported by a Health Professional from on Feb 08, 2005. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , body temperature increased, bradycardia, haemoglobin decreased, hypertension, neutropenia, tachycardia, ventricular dysfunction, white blood cell count decreased. Clolar dosage: 112 MG QD IV. During the same period patient was treated with VANCOMYCIN, CEFTAZIDIME, FLUCONAZOLE, PENTAMIDINE, FLAGYL. Patient recovered.

Clolar Side Effects Report #4594691-2
Clolar side effect was reported by a Consumer or non-health professional from on Feb 08, 2005. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , bradycardia, hypertension, neutropenia, tachycardia, ventricular dysfunction. Clolar dosage: 112 MG QD IV. During the same period patient was treated with VENCOMYCIN, CEFTAZIDIME, FLUCONAZOLE, PENTAMIDINE, FLYGAYL. Patient recovered.

Clolar Side Effects Report #4623641-5
Clolar side effect was reported by a Physician from on Mar 15, 2005. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood urea increased, body temperature increased, bradycardia, haemoglobin decreased, hypertension, neutropenia, tachycardia, ventricular dysfunction. Clolar dosage: 112 MG QD; IV. During the same period patient was treated with VANCOMYCIN, CEFTAZIDIME, FLUCONAZOLE, PENTAMIDINE, FLAGYL. Patient recovered.

Clolar Side Effects Report #4626406-3
Clolar side effect was reported by a Physician from on Mar 15, 2005. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood urea increased, body temperature increased, bradycardia, haemoglobin decreased, hypertension, neutropenia, tachycardia, ventricular dysfunction. Clolar dosage: 112 MG QD IV. During the same period patient was treated with VANCOMYCIN, CEFTAZIDIME, FLUCONAZOLE, PENTAMIDINE, FLAGYL. Patient recovered.

Clolar Side Effects Report #5814196-8
Clolar side effect was reported by a Consumer or non-health professional from UNITED STATES on July 08, 2008. Female patient was diagnosed with acute leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood alkaline phosphatase increased, ejection fraction decreased, rash , renal failure acute. Clolar dosage: 30 MG/M2, QDX5, INTRAVENOUS. Patient died.